Caitong International Asset Management Co., LTD Prothena Corp Public LTD CO Transaction History
Caitong International Asset Management Co., LTD
- $102 Billion
- Q4 2024
A detailed history of Caitong International Asset Management Co., LTD transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 115 shares of PRTA stock, worth $1,599. This represents 0.0% of its overall portfolio holdings.
Number of Shares
115
Previous 115
-0.0%
Holding current value
$1,599
Previous $1.59 Million
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding PRTA
# of Institutions
197Shares Held
44.5MCall Options Held
601KPut Options Held
259K-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$161 Million7.5% of portfolio
-
Wellington Management Group LLP Boston, MA5.13MShares$71.4 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.86MShares$53.7 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.69MShares$51.3 Million0.01% of portfolio
-
Armistice Capital, LLC New York, NY2.24MShares$31.1 Million0.44% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $653M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...